Mark Sheptoff Financial Planning’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
Other funds holding HQL
NIM
WAM
FHA
AAM
MC
CRC
Mark Sheptoff Financial Planning's HQL Position: Q1 2020 in Review
Mark Sheptoff Financial Planning sold out of abrdn Life Sciences Investors (HQL) in Q1 2020, closing a stake of 500 shares — an estimated $9K sold.
Mark Sheptoff Financial Planning first reported a position in HQL in Q1 2014 and held it in 19 quarters. The position peaked at $14K in Q3 2017. 69 funds tracked by Wall St. Rank hold HQL as of Q1 2020.
- Mark Sheptoff Financial Planning reported no remaining abrdn Life Sciences Investors position as of Q1 2020 after selling out during the quarter.
- Mark Sheptoff Financial Planning sold 500 abrdn Life Sciences Investors shares in Q1 2020, an estimated $9K.
- Mark Sheptoff Financial Planning first reported a position in abrdn Life Sciences Investors in Q1 2014 and held it in 19 quarters.
- Mark Sheptoff Financial Planning's abrdn Life Sciences Investors position peaked at $14K in Q3 2017.
- 69 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2020.
Based on Mark Sheptoff Financial Planning's 13F filing for Q1 2020, filed 7 May 2020.